Dr. Chantal Devillena, MD
What this data tells you about Dr. Devillena
Dr. Chantal Devillena is a dermatology specialist in San Antonio, TX, with 18 years of NPI registration. Based on federal Medicare data, Dr. Devillena performed 28,170 Medicare services across 4,591 unique beneficiaries.
Between the years covered by Open Payments, Dr. Devillena received a total of $7,897 from 41 pharmaceutical and/or device companies across 438 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Devillena is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Photodynamic therapy gel for precancerous skin | 19,000 | $1 | $5 |
| Destruction of precancerous skin growths, 2-14 | 3,213 | $5 | $20 |
| Office visit, established patient (30-39 min) | 1,855 | $84 | $155 |
| Destruction of precancerous skin growth, 1 | 1,016 | $35 | $95 |
| Skin biopsy, tangential | 671 | $60 | $145 |
| Destruction of skin growths (warts/lesions), 1-14 | 532 | $81 | $135 |
| Office visit, established patient (20-29 min) | 353 | $62 | $110 |
| Biopsy of related skin growth, each additional growth | 233 | $37 | $80 |
| Destruction of precancer skin growth, 15 or more growths | 208 | $116 | $285 |
| Steroid injection (triamcinolone) | 149 | $1 | $5 |
| Destruction of skin growth, 15 or more growths | 144 | $87 | $160 |
| Therapy procedure using ultraviolet radiation with tar or petroleum jelly application | 125 | $88 | $150 |
| Application of light to destroy precancer skin growth | 106 | $103 | $170 |
| Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | 104 | $221 | $365 |
| New patient office visit (45-59 min) | 98 | $102 | $200 |
| Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | 87 | $94 | $295 |
| Injection into skin growth, more than 7 growths | 39 | $45 | $90 |
| Biopsy of ear | 30 | $45 | $145 |
| Punch biopsy, first skin growth | 26 | $89 | $185 |
| Removal of noncancer skin growth of body, arms, or legs, 1.1-2.0 cm | 24 | $66 | $205 |
| Acne surgery | 22 | $68 | $140 |
| Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | 22 | $98 | $180 |
| Office visit, established patient, complex (40-54 min) | 21 | $128 | $250 |
| Simple or single drainage of skin abscess | 19 | $88 | $150 |
| Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | 17 | $278 | $425 |
| Drug injection, under skin or into muscle | 15 | $11 | $30 |
| New patient office visit (30-44 min) | 15 | $82 | $140 |
| Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | 14 | $112 | $215 |
| Biopsy of lip | 12 | $62 | $165 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Devillena is a mixed practice specialist, with above-average Medicare volume (top 1% in TX), with low-engagement industry engagement, with 18 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Devillena experienced with photodynamic therapy gel for precancerous skin?
Does Dr. Devillena receive payments from pharmaceutical companies?
How do Dr. Devillena's costs compare to other dermatologists in San Antonio?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology